DNM2 and acute lymphoblastic leukemia: Coherently, recurrent loss-of-function mutations in the dynamin 2 (DNM2) gene were found to impair clathrin-dependent endocytosis of IL-7R leading to increased surface expression and enhanced IL-7R signaling in T-ALL cells.